Advertisement
Videos
Advertisement

The growing trend of stealth investment and big pharma's venture into rare disease indications.

Wed, 10/20/2010 - 6:20am
3B Nexus

SCRIP editor, Mike Ward and contributing editor, John Hodgson discuss the trend of stealth investment and big pharma's foray into rare disease indications.

You need to upgrade your Flash Player!

This web site makes use of the Macromedia Flash player 8.

VIDEO PLAYER by 3b nexus

Topics

Advertisement
Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading